AHA Issues Scientific Statement On Infective Endocarditis

December 21, 1998

American Heart Association Journal Report:

DALLAS, Dec. 22 -- The American Heart Association today issues a new scientific statement that updates the procedures for diagnosing and treating infective endocarditis, a life-threatening heart infection that can be caused by common microbes such as streptococcus or "strep."

The statement by the AHA's Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease is published in today's Circulation: Journal of the American Heart Association.

Infective endocarditis (IE) occurs when bacteria or fungus cause severe infections in the inner lining of the heart or heart valves, leading to tissue damage or destruction. Antibiotics can usually treat the bacterial infections, but if the disease is not detected, the infection can gradually destroy the heart lining or heart valves. Also, clumps of the bacteria can break off and travel through the blood vessels to other organs, including the brain. This can cause serious injury to these organs or even death.

About 20,000-30,000 people develop IE, a disease that represents the fourth leading cause of life-threatening infections such as pneumonia, according to Kathryn A. Taubert, Ph.D., senior scientist in the AHA's department of science and medicine and a co-author of the statement.

Individuals at risk for IE include people with certain defects of the heart present at birth, heart valve disorders, mitral valve prolapse, a history of rheumatic heart disease, or anyone who has an artificial heart valve.

Individuals who are intravenous drug abusers are also at high risk for IE. The statement is the first from the American Heart Association to recommend the set of diagnostic criteria for IE developed by researchers at Duke University Medical Center. The previous diagnostic criteria relied on tests that measured bacteremia (high amounts of bacteria in the blood), regurgitant murmur (a heart abnormality) and blood vessel complications. The new diagnostic strategy includes using a procedure called echocardiography that provides an ultrasound image of the heart to detect infection.

Previous AHA statements provided guidelines for preventing endocarditis and treating the more common forms. The new guidelines, however, include information about treating some of the more unusual causes of IE such as Legionella, a bacteria that can develop in individuals who have prosthetic cardiac valves, or fungal infections such as Candida, Aspergillus, and Pseudomonas that are often found as the cause of IE among intravenous drug users, or in individuals who have central venous catheters.

"The guidelines from Duke work almost like a checklist," Taubert says. "They can help a physician be more certain in the diagnosis because endocarditis can mimic a lot of other diseases, especially in its early stages.

"Although advances in antimicrobial therapy and the development of better diagnostic and surgical techniques have reduced the number of individuals who die from bacterial endocarditis, it remains a life-threatening disease. That's why it is important to recognize and manage the major complications, such as heart failure and infections."

The Duke guidelines offer three categories of diagnosing endocarditis to help physicians manage patients who are affected. The categories include: 1) "definite" cases proven at surgery; 2) "possible" cases, which means there is some evidence of IE, but not as much evidence as a "definite" case; and 3) "rejected" cases, meaning there is a diagnosis other than IE, or the symptoms of the illness resolve after four or more days of antibiotic therapy.

Co-authors are Arnold S. Bayer, M.D.; Ann F. Bolger, M.D.; Walter Wilson, M.D.; James Steckelberg, M.D.; Adolph W. Karchmer, M.D.; Matthew Levison, M.D.; Henry F. Chambers, M.D.; Adnan S. Dajani, M.D.; Michael H. Gewitz, M.D.; Jane W. Newburger, M.D.; Tommy W. Gage, R.Ph., D.D.S., Ph.D.; and Patricia Ferrieri, M.D.
-end-
NR 98-4599 (Circ/Taubert)
Media advisory: Dr. Taubert may be reached by phone at (214) 706-1455 or by fax at (214) 373-0268. (Please do not publish numbers.)

For journal copies only,
please call: (214) 706-1173

For other information, call:
Brian Henry: (214) 706-1135 or
Carole Bullock: (214) 706-1279

American Heart Association

Related Bacteria Articles from Brightsurf:

Siblings can also differ from one another in bacteria
A research team from the University of Tübingen and the German Center for Infection Research (DZIF) is investigating how pathogens influence the immune response of their host with genetic variation.

How bacteria fertilize soya
Soya and clover have their very own fertiliser factories in their roots, where bacteria manufacture ammonium, which is crucial for plant growth.

Bacteria might help other bacteria to tolerate antibiotics better
A new paper by the Dynamical Systems Biology lab at UPF shows that the response by bacteria to antibiotics may depend on other species of bacteria they live with, in such a way that some bacteria may make others more tolerant to antibiotics.

Two-faced bacteria
The gut microbiome, which is a collection of numerous beneficial bacteria species, is key to our overall well-being and good health.

Microcensus in bacteria
Bacillus subtilis can determine proportions of different groups within a mixed population.

Right beneath the skin we all have the same bacteria
In the dermis skin layer, the same bacteria are found across age and gender.

Bacteria must be 'stressed out' to divide
Bacterial cell division is controlled by both enzymatic activity and mechanical forces, which work together to control its timing and location, a new study from EPFL finds.

How bees live with bacteria
More than 90 percent of all bee species are not organized in colonies, but fight their way through life alone.

The bacteria building your baby
Australian researchers have laid to rest a longstanding controversy: is the womb sterile?

Hopping bacteria
Scientists have long known that key models of bacterial movement in real-world conditions are flawed.

Read More: Bacteria News and Bacteria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.